Was checking the social twitter for price-buy target in at $1.85 thereof.
Someone just commented on a spat of comments re. the company's TNK CAR IP for use in placenta-derived and cord-blood derived cells via twitter with a citation of 18 under Subsequent Events re. Celularity Note and Nonbinding Joint Venture Termsheet.. Very interesting spat of comments .... hence this could be the downfall of its price to S$1? We shall see ...
Not vested yet. A safe margin to buy will be below S$1 ...